Misoprostol compared to oxytocin for postpartum hemorrhage
DOI:
https://doi.org/10.17267/2675-021Xevidence.2021.e3733Keywords:
Postpartum hemorrhage. Oxytocin. Misoprostol. Uterotonics. Obstetrics.Downloads
References
Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;12:CD011689. https://doi.org/10.1002/14651858.cd011689.pub2
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-333. https://doi.org/10.1016/s2214-109x(14)70227-x
World Health Organization. WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage [Internet]. Geneva: World Health Organization; 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/277276/9789241550420-eng.pdf?ua=1
Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168-e186. https://doi.org/10.1097/aog.0000000000002351
Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012;(8):CD000494. https://doi.org/10.1002/14651858.cd000494.pub4
Smith WRP, Papadopoulou A, Thomas E, Tobias A, Price MJ, Meher S, et al. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2020;11:CD012754. https://doi.org/10.1002/14651858.cd012754.pub2
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Brit Long, Michael Gottlieb
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain copyrights, transferring to the Journal of Evidence-Based Healthcare only the right of first publication. This work is licensed under a Creative Commons Attribution 4.0 International License.
